AI-based technology aimed at accelerating drug development progress in oncology
QurieGen has raised €2.2M across 1 funding round from 5 investors, most recently a Pre-Seed round in Apr 2025. Based in Nijmegen, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-04-08 | Pre-Seed | €2.2M |
| 22 Hor Invest,BSV Ventures,Lighthouse Ventures,Moondust Ventures,Tensor Ventures |
| View deal → |
